These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1441821)

  • 21. Identification of glycosaminoglycans using high-performance liquid chromatography on a hydroxyapatite column.
    Narita H; Takeda Y; Takagaki K; Nakamura T; Harata S; Endo M
    Anal Biochem; 1995 Nov; 232(1):133-6. PubMed ID: 8600821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Levels of serum soluble tumor necrosis factor receptor in patients with lung cancer].
    Yan GM; Lui JY; Yang HZ
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):515, 517. PubMed ID: 12212141
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glycosaminoglycans--structure and function].
    Głowacki A; Koźma EM; Olczyk K; Kucharz EJ
    Postepy Biochem; 1995; 41(2):139-48. PubMed ID: 7479442
    [No Abstract]   [Full Text] [Related]  

  • 27. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
    Higuchi Y
    Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elastin metabolism parameters in sera of patients with lung cancer.
    Gmiński J; Mykala-Cieśla J; Machalski M; Drózdz M
    Neoplasma; 1993; 40(1):41-4. PubMed ID: 8394514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate.
    Poole AR; Witter J; Roberts N; Piccolo F; Brandt R; Paquin J; Baron M
    Arthritis Rheum; 1990 Jun; 33(6):790-9. PubMed ID: 2141981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratan sulfate levels in sera of patients bearing cartilage tumors.
    Kliner DJ; Gorski JP; Thonar EJ
    Cancer; 1987 Jun; 59(11):1931-5. PubMed ID: 2952259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in keratan sulphate levels in the serum of a long distance runner.
    Hinnie J; Jankowski JA; Brankin EB; Sturrock RD
    Br J Rheumatol; 1990 Aug; 29(4):314-5. PubMed ID: 2143095
    [No Abstract]   [Full Text] [Related]  

  • 33. Increase in serum concentration of keratan sulfate after treatment of growth hormone deficiency with growth hormone.
    Pachman LM; Green OC; Lenz ME; Hayford J; Thonar EJ
    J Pediatr; 1990 Mar; 116(3):400-3. PubMed ID: 2137876
    [No Abstract]   [Full Text] [Related]  

  • 34. Measurement of heparan sulphate in normal human serum by laser nephelometry.
    Warren C; Manley G
    Clin Chim Acta; 1984 Mar; 137(3):355-9. PubMed ID: 6230179
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular markers of metabolic changes in osteoarthritis.
    Thonar EJ
    Osteoarthritis Cartilage; 1999 May; 7(3):338-9. PubMed ID: 10329323
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative determination of individual glycosaminoglycans in plasma by concanavalin A rocket electrophoresis.
    Staprans I; Felts JM; Butts RJ
    Anal Biochem; 1983 Oct; 134(1):240-4. PubMed ID: 6660493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Content of sulphated glycosaminoglycans in blood serum and urinary excretion of oxyproline in patients with diabetes mellitus].
    Dozorets IuL; Okorokov AN; Bobkov VIa
    Vrach Delo; 1976 Apr; (4):92-4. PubMed ID: 1007213
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of serum hyaluronic acid in bronchial carcinoma].
    MASENTI E; MERLO G
    Minerva Chir; 1960 Mar; 15():264-7. PubMed ID: 14421998
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel glycosaminoglycan in sera of diabetics.
    Nagamura Y; Korthaus G; Kolb H; Gries FA; Drost H
    Lancet; 1981 Mar; 1(8221):665-6. PubMed ID: 6110888
    [No Abstract]   [Full Text] [Related]  

  • 40. Venous occlusion test for the release of heparan sulfate from endothelium.
    Hladovec J; Sommerová Z; Prerovský I
    Thromb Res; 1993 Nov; 72(4):359-61. PubMed ID: 8303677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.